Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
225,970,109
-
Number of holders
-
1,024
-
Total 13F shares, excl. options
-
221,960,038
-
Shares change
-
-473,061
-
Total reported value, excl. options
-
$50,395,003,088
-
Value change
-
-$269,286,785
-
Put/Call ratio
-
99%
-
Number of buys
-
467
-
Number of sells
-
545
-
Price
-
$227.04
Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q1 2020
As of 31 Mar 2020 Elevance Health, Inc. - Common Stock (ELV) had 1,024 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 221,960,038 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Capital International Investors, FMR LLC, Invesco Ltd., BAILLIE GIFFORD & CO, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 1,025 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.